Hope Medicine Doses First Patient in HMI-115 Phase III – First-in-Class Non-Hormonal Endometriosis Therapy Advances in China
Hope Medicine Inc. announced first patient dosing in a Phase III clinical study evaluating HMI-115,...
Hope Medicine
Hope Medicine Initiates Phase II Trial for HMI-115 in Endometriosis Treatment
Hope Medicine Inc., based in China, has announced the first patient dosing in a global...
Hope Medicine Gains Global Approval for Phase II Trial of HMI-115
China-based Hope Medicine Inc. has announced receiving approval to conduct a global multi-center Phase II...